Refine by
Diabetic Complications Equipment & Supplies
33 equipment items found
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
MPC-300-IV is being developed for the treatment of diabetic complications, including diabetic kidney disease known as diabetic ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Hirudin has potent anti-thrombotic, wound repair, anti-fibrosis, anti-tumor and anti-hyperuricemia effects. Hirudin also affects diabetic complications, cerebral hemorrhage, and ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Benfotiamine (S-Benzoylthiamine O-monophosphate) is a vitamin B1 derivative that exhihibits potent antioxidative and anti-inflammatory activity. Benfotiamine can be used for the research of various secondary diabetic complications. Benfotiamine also can be used in infectious diseases such as HIV and ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Thiamine hydrochloride has neuroprotective and anti-inflammatory effects. Thiamine hydrochloride can be used in the studys of diabetic complications, neurological diseases, cancers, and ...
Manufactured by:Origin, Inc based inPrinceton, NEW JERSEY (USA)
Dermatological applications for Nitric Oxide. Our initial target indication is onychomycosis . Nitric Oxide Treatments for Dermatological ...
Manufactured by:Angionica Ltd. based inLodz, POLAND
AngioExpert is a medical device which uses the FMSF-PORH method to evaluate microvascular circulation. ...
Manufactured by:Owen Mumford Ltd. based inOxfordshire, UNITED KINGDOM
An effective aid to peripheral neuropathy foot screening. Diabetic peripheral neuropathy is one of the most common complications of diabetes, potentially leading to loss of sensation, foot ulcerations and eventually amputation¹. Treatment of these complications can be expensive² yet many are avoidable³, making ...
Manufactured by:Epinex Diagnostics Inc based inTustin, CALIFORNIA (USA)
The Epinex G1A™ Rapid Diabetes Monitoring Index Test*. A monthly test for the control of glycation, the underlying cause of the complications of diabetes. The only rapid test for measuring Glycated Albumin, a superior marker for diabetes control. Allows earlier therapeutic intervention. Encourages self-management. Promotes ...
Manufactured by:HTL-Strefa S.A. based inOzorków, POLAND
Most of the food we eat is turned into glucose, or sugar, for our bodies to use for energy. Diabetes is a disease in which the body is unable to properly use and store glucose. Glucose backs up in the bloodstream — causing one’s blood glucose to rise too ...
Manufactured by:Ikarovec based inNorwich, UNITED KINGDOM
Diabetic macular edema (DME) is the most common cause of sight loss in diabetics. The longer you have diabetes, the greater your chance of developing sight loss. About 90% of people with type 1 diabetes will have some degree of retinopathy after 10 years. For people with type 2 diabetes, the chance of developing ...
Manufactured by:Meda BioTech, Inc. based inWest Berlin, NEW JERSEY (USA)
Using a proprietary formula for better absorption. 30 Capsules per ...
Manufactured by:Tosoh India Pvt. Ltd. based inMumbai, INDIA
Tosoh Bioscience’s HLC-723GX, automated glycohemoglobin analyzer is the latest addition in the Tosoh HPLC family that continues to set the standard for diabetes diagnosis and monitoring. The HLC-723GX offers all the qualities of Tosoh's best-in-class HLC-723G8 analyzer, for low volume HbA1c testing requirements. The HLC-723GX produces stable HbA1c results with variant detection in 2.2 ...
by:Vidan Diagnostics based inSan Antonio, TEXAS (USA)
Lucidplus™ allows you to monitor DKA patients with the convenience of using this device anywhere in your facility. 1Utilizing point-of-care β-OHB testing has the potential to reduce comprehensive laboratory evaluations for DKA among hyperglycemic emergency-department ...
Manufactured by:RheoMeditech Inc. based inSeoul, SOUTH KOREA
RheoSCAN-AnD300 can measure comprehensive rheological properties of blood within a short time (< 2 min). Now, RBC deformability, aggregation and aggregating force can be easily measured with a leading-edge microfluidic ...
Manufactured by:Oramed Pharmaceuticals, Inc. based inNew York, NEW YORK (USA)
Diabetes is a chronic condition characterized by hyperglycemia, or elevated blood glucose levels. If left untreated, diabetes may lead to complications such as cardiovascular disease, chronic renal failure, retinopathy and ...
Manufactured by:Clearside Biomedical based inAlpharetta, GEORGIA (US) (USA)
As part of our small molecule program, we are evaluating the suprachoroidal administration of an integrin inhibitor suspension. Integrins play a role in pathologic processes, such as inflammation, angiogenesis and fibrosis. Suprachoroidal delivery of an integrin inhibitor suspension could provide targeting, compartmentalization and durability advantages over topical or intravitreal delivery, ...
by:Securecell AG based inUrdorf, SWITZERLAND
Seraccess® was forged from Securecell’s expertise in automating and digitalizing the biotechnology space. Our immense knowledge of connecting expansive bioprocessing systems, microfluidics and documenting processes down to the molecular level led us to solutions that could greatly impact the Artificial Pancreas Device System (APDS) market for a significantly underserved diabetes ...
Manufactured by:Bluedrop Medical based inGalway, IRELAND
Remote patient monitoring (RPM) for patients at risk of diabetic foot disease. Thermal and visual assessment in a single scan. Award winning, patented design. Enhancing the connection between patient and wound care ...
by:Modular Medical, Inc. based inSan Diego, CALIFORNIA (USA)
The MODD1 was designed to be affordable enough for free sampling and trial, and simple enough for self-guided user training and use. This is the product the industry has needed to take the step into ...
Manufactured by:Arkray USA, Inc. based inMinneapolis, MINNESOTA (USA)
Highly Accurate1 Blood Glucose Testing in a Feature-focused System. Tight glycemic control can reduce the risk of diabetes-related complications by at least 42%*.2. * 76% reduced risk of eye disease; 50% reduced risk of kidney disease; 60% reduced risk of nerve disease; 57% reduced risk of nonfatal heart attack, stroke, or death from cardiovascular causes; 42% ...